BMP at later stages (16) . The high content of CHOL and the low content of BMP in exosomes are in agreement with the idea that exosomes originate from MVBs at earlier stages (16) . However, it has also been reported that there are different classes of MVBs, some that fuse with lysosomes and others that give rise to exosomes (17) .
In this review, we will discuss the available information about the lipid composition of exosomes, including both lipid classes and lipid species. In addition, methodological issues related to the study of exosomal lipids will be dis cussed. Finally, the role of ether lipids and phosphoinositides (PIPs) in exosome biology will be presented.
EXPERIMENTAL CONSIDERATIONS IN THE STUDY OF EXOSOMAL LIPIDS
A caveat of exosome research is that the field has devel oped exponentially during the last decade without having a clear consensus on the optimal methodological ap proaches. This has caused confusion in the scientific com munity and, in some cases, results might have been misinterpreted or are based on unsatisfactory purification methods. In this section, these issues are briefly com mented on in the context of exosomal lipids, and we refer to our recent review for a more extensive discussion about this topic (18) . Based on the studies published so far, exo somes are constituted to a large extent of membrane lipids, although it is possible that minor amounts of other lipids are captured from the cytosol during the formation of ILVs. The exosomal lipid composition should therefore normally be in agreement with the composition of a lipid bilayer. It is wellestablished that there is an asymmetric dis tribution of lipid classes in the two leaflets of the plasma membrane. Thus, sphingolipids and phosphatidylcholine (PC) are mostly present in the outer leaflet, and the other lipid classes are mainly located in the inner leaflet (19) . One should expect a similar asymmetry in exosomal mem branes, at least shortly after exosomes are released from cells. Thus, at least in mammalian cells, quantitative lipid analyses can be used to estimate whether the reported lipid data are in agreement with small vesicles with a bilayer structure. In contrast to exosomes, some EVs in human se men have been reported to contain internal membranes (20) , which may complicate such analysis.
Recently, several articles have been published describing errors and limitations in lipidomic analyses and how they can be improved (21, 22) . It was stressed that fatty acyl groups with an odd number of carbon atoms are present in limited amounts in cells, and data reporting large amounts of such fatty acyl groups should be interpreted with caution (22) .
Several studies have reported high levels of cholesteryl ester (CE), triacylglycerol (TAG), and cardiolipin in exo somal preparations. CE and TAG are normally found in the core of lipid droplets (19) and cardiolipin in the inner membrane of mitochondria (23, 24) . Therefore, high levels of these lipids in exosome preparations may indicate that lipid droplets, lipoproteins, or mitochondria have been coisolated with exosomes. Lipid droplets and mito chondria could potentially be leaked into the extracellular medium and later be coisolated with exosomes if, during the time exosomes are allowed to accumulate in the me dium, some cells die and their membrane is broken. In addition, both organelles can be included in autophagic vesicles (25) , secreted by secretory autophagy, and eventu ally coisolated with exosomes during the isolation process (26) . A combination of lipidomic and proteomic analysis can provide interesting information about the origin of the different types of vesicles that are present in EV prepara tions. However, there is certainly a need for better methods to purify and characterize the different types of EVs (18, (27) (28) (29) . When reviewing the literature, it is difficult to evaluate the purity of the exosome preparations and, in this review, some studies where lipid analyses reveal the pres ence of lipids not expected to be present in exosomes, the plasma membrane, or endosomal membranes are com mented on.
It is important to include as much quantitative lipid data as possible in the articles. Lipid amounts are often given as nanomoles per milligram or as mole percent of total lipids and, preferably, both values should be reported. The use of mole percent has, in fact, some advantages, as it eliminates uncertainties in the measurement of protein concentrations that may occur by using, for example, different standard proteins or methods for protein analyses. Furthermore, in order to evaluate the importance of a specific treatment, the amount of the different lipids should be provided, not just the percent changes from cells to exosomes.
Finally, in terms of studies of exosome biogenesis and release, it should be considered that there may be cell type dependent regulatory mechanisms for the biogenesis and release of exosomes. For example, Trajokovic et al. (30) reported that inhibition or siRNAmediated depletion of neutral SMase, an enzyme that generates ceramide (Cer) from SM, resulted in reduced secretion of exosomes from Olineu cells. Later, a similar effect of neutral SMase was reported in the human embryonic kidney cell line, HEK293 (31) , and in Tcells (32) . However, the action of neutral SMase does not seem to be required for exosome release in all cell lines tested (33, 34) . Furthermore, different MVB subtypes within a single cell line might exploit different pathways, as shown for syntenincontaining exosomes released from MCF7 cells (35) .
COMPOSITION OF LIPID CLASSES IN EXOSOMES DERIVED FROM KNOWN CELL TYPES
The lipid composition of exosomes described in 10 stud ies as well as the enrichment factors from cells to exosomes in 8 of them are shown in Table 1 . Interestingly, these studies show a two to three times enrichment from cells to exosomes of CHOL, SM, glycosphingolipids, and phosphatidylserine (PS). In general, these data show a similar mole percent of phosphatidylethanolamine (PE) in cells and exosomes, and a lower mole percent of PC and PI in exosomes than in their parent cells. Some years ago, we published an exten sive quantitative lipid analysis of PC3 cells and their exo somes (36) . The relative changes for 22 lipid classes are shown in (Fig. 2) , and the quantitative data for 14 of them are shown in the first column of Table 1 . Another study of prostate cell lines, including PC3 cells, also shows a similar enrichment of sphingolipids from cells to exosomes, but the phospholipid classes were grouped together making it difficult to compare these data with other studies (37) . Moreover, a lipidomic study of PC3 cells treated with a pre cursor (hexadecylglycerol) of ether phospholipids has also been performed. Although this treatment resulted in ma jor changes in the lipidome of cells and their exosomes, similar enrichment factors were obtained from cells to exo somes in cells treated with hexadecylglycerol compared with untreated cells (36, 38) , as shown in Table 1 and dis cussed in (18) . Lipidomic analysis of Olineu cells (30) and HepG2/C3a cells (39) showed many similarities with PC3 cells, although Olineu cells showed less enrichment of SM and a much higher enrichment of Cer in exosomes (Table 1) . Because these studies did not include the CHOL content as percent of total lipids, we have, for comparison, assumed that it constituted 43 mol%, i.e., the same level as in other exosome preparations listed in Table 1 .
In the studies discussed above, MS was used for lipid quantification. In older studies of exosomes derived from Blymphocytes (40) , mast cells (41) , and dendritic cells (41), lipid analyses were performed with TLC and/or gas liquid chromatography (GLC). In these studies, some lipid classes migrated as one band, including PS, later reported to be enriched from cells to exosomes, and PI, for which the opposite has been reported (Table 1) . Therefore, it is difficult to compare some of these results with the men tioned MS studies, but, as shown in Table 1 , several similari ties exist between all these exosome preparations.
The data shown for reticulocytes in Table 1 are from the very first study describing the lipid composition of exo somes and their parent cells (42) . Only a slight enrichment of SM and a small decrease in the mole percent of PE are observed when these exosomes are compared with their parent cells. This may be due (at least partially) to the high CHOL content in these cells and/or the nature of the MVBs that fuse with the plasma membrane in reticulocytes, because they have been shown to contain markers of early, not late, endosomes (43) . Interestingly, analyses of exo somes isolated after 2, 4, and 7 days of in vitro reticulocyte differentiation revealed major changes in several lipid classes, i.e., PE, PI + PS, and SM (44) . In particular, from day 2 to day 7, the PE content increased by approximately 70%, SM decreased by approximately 40%, and the sum of PI and PS decreased by approximately 50%.
The two last columns in Table 1 show the lipid composi tion of exosomes released from platelets (45) and adipo cytes (46) . The enrichment factors are not included because the lipid composition of the parent cells was not reported. Compared with other exosomes shown in Table 1 , the adipocyte exosomes contain higher amounts of PC and lower amounts of PS (46) . In order to make these data fit with a bilayer membrane, almost half of the PC mole cules have to be in the inner leaflet. However, the lipid composition of exosomes released from platelets is very similar to exosome preparations from other cells ( Table 1) . The authors also reported the lipid composition of five other EV fractions with a size somewhat larger than the exosome preparation (the six preparations showed diame ters in the range of 106-203 nm, as measured by nanopar ticle tracking analyses). This study nicely demonstrates how EVs of different sizes can have different lipid compositions. To illustrate this, the percentage of some lipid classes in exosomes and the percentage range observed in the other five fractions (in parentheses) is shown: CHOL 42.5% (30.8-37.1%), SM 12.5% (6.0-8.0%), PS 10.5% (13.9-18.9%), and PI 5.2% (2.5-3.9%) (45) . In agreement with this and with previous results about the rigidity of exosomal membranes (41) , analysis of three different types of EVs (exosomes, microvesicles, and apoptotic bodies) from BV2 cells showed that exosomes have a remarkably higher lipid order than microvesicles or apoptotic bodies (47) . In addi tion, the same group showed that exosomes from several cell lines were less sensitive to detergents than apoptotic bodies and microvesicles (48) .
A lipidomic study in LIM1215 colorectal cancer cells identified 500 lipid species (49) . These data are not listed in Table 1 , as only the relative abundance of lipid species in cells and exosomes were shown. The enrichment factors are very different from those reported in other studies, and the high enrichment of TAG (×24) and CE (×5.7) should have been further investigated to exclude the possibility that lipoparticles and/or lipid droplets were present in the exosomal preparations. A study in U87 glioblastoma cells, Huh7 hepatocellular carcinoma cells, and human bone marrowderived mesenchymal stem cells of both exosomes and microvesicles has also been published (50) . In contrast to many studies, a similar content of SM and PS as percent of total lipids in exosomes and parental cells was reported, whereas the amount of PC and PI were more similar to other studies (50) .
To our knowledge, there is only one study where the lipid composition of exosomes secreted from the apical and the basolateral membrane of polarized cells has been compared (51) . The exosomes released from the apical and basolateral membrane of polarized murine cortical collecting duct principal cells had mean diameters of 148 nm and 100 nm, respectively. Interestingly, approximately three times more exosomes were obtained from the apical than from the basolateral side, and large differences in the lipid composition of these exosomes were found. However, it is difficult to evaluate these data due to the different rela tive exosomal lipid composition that is obtained depend ing on the MS analysis mode (negative or positive ion). Furthermore, the very high content of cardiolipin, a lipid 
As mentioned in the Introduction, BMP can be present in the membranes of the ILVs of MVBs (16) . Only a few studies have investigated the presence of this lipid in exo somes. In one study, BMP was reported to be below the detection limit (40) , and in the other, this lipid accounted for 0.8 and 1.2 mol% of total phospholipids in exosomes and cells, respectively (41) . A third study, based on elec tron microscopy, found low labeling of BMP in exosomes (16) , but it should be noted that this technique is sensitive to fixation and the amount of BMP may have been under estimated. The lack of enrichment of BMP in exosomes is in agreement with the idea that the main destination for BMP is the lysosomes, where it seems to be an important cofactor for sphingolipid catabolism and to contribute to lysosomal stability and integrity (52, 53) 
Finally, as shown in Table 1 , PI is generally found in exo somes. PIPs are phosphorylated derivates of PI that help in specifying organelle identity. In particular, PI(3)P and PI3,5bisphosphate [PI(3,5)P 2 ] contribute to the identity of early and late endosomes (55, 56) . Unfortunately, quan tification of PIPs by MS is not straightforward, as PIs phos phorylated at one or two sites have to be separated by chromatography in order to be identified. To our knowl edge, there are no studies reporting quantification of PIPs in exosomes so far.
In conclusion, exosomes released from different cell lines have a relatively similar composition of lipid classes in general. Additional experiments in more cellular systems are necessary to further support this idea. It will also be in teresting to compare the lipid composition of exosomes and other EVs in other cell types. Moreover, the lipid com position of exosomes, HIV particles (57), and detergent resistant membranes (58) show several similarities, and this is discussed in detail in (18) . In agreement with this, a very recent article showed that the lipid composition of encap sulated hepatitis E virus from HEpG2/C3a cells and exo somes released from these cells was very similar (39) . Moreover, the lipid content of the hepatitis Econtaining particles was very similar to HIV particles (57) and to many of the exosome preparations discussed above.
COMPOSITION OF LIPID CLASSES IN EXOSOMES DERIVED FROM BIOLOGICAL FLUIDS
Exosomes in biological fluids constitute a heterogeneous population originating from many different cell types. Due to the complex composition of biofluids, the possibility of coisolating exosomes with other vesicles, particles, or proteins is higher than in more controlled systems, such as cell culture supernatants. In this section, we have used the terms that the authors have chosen to name their EVs.
Only a few studies have investigated the lipid composi tion of EVs in biofluids. The lipid composition of EVs from seminal fluid, traditionally called prostasomes, was analyzed some years ago by TLC in human (59), horse (60) , and boar semen (61) . The results of these studies show several similarities with the data discussed in the previous section. However, recent MS analyses of two prostasome fractions of 100 and 50 nm in diameter purified from human semi nal fluid (Table 2) show that the sphingolipid [SM and hexosylceramide (HexCer)] content varies considerably between the two populations, and that it is higher than that reported for exosomes in Table 1 (62) . The third column of Table 2 shows the lipid composition of human urinary exosomes that we reported based on the quantification of 107 lipid species by MS analysis (63) . There are some im portant differences between the lipid composition of uri nary exosomes and our data of exosomes derived from PC3 cells (36) . For example, the CHOL content (63 mol%) of urinary exosomes is on the limit of what model membranes have been shown to accommodate (64).
Blans et al. (65) recently published a study of EVs iso lated from human and bovine milk that included informa tion about their phospholipid and TAG composition. The mode diameter of these EVs was reported to be in the range of 147-189 nm, with some vesicles being up to 700 nm. The authors concluded that milk EVs likely contain various EV subsets. Importantly, it was shown that the iso lated preparations were not just milk fat globules, as the ratio of TAG to CHOL was lower in the vesicle preparations than in the globules. EVs are also found in blood (66), but we are not aware of any lipidomic study of EVs isolated from whole blood. The complexity of blood and the high content of lipoparticles in this biofluid make it difficult to isolate pure EV preparations, and thus to interpret the lipid composition of blood EVs (67).
ETHER LIPIDS IN EXOSOMES
Ether lipids have not obtained much attention so far, considering that they constitute a considerable fraction of membrane lipids. Moreover, ether lipids are still hardly mentioned in cell biology text books, even though they have been known for many years. The advances in MS anal yses seen in recent years have increased the interest for ether phospholipids. In addition to the discussion below, we refer to the following articles for ether lipid structure and general information about these lipids (68) (69) (70) (71) (72) (73) .
Interestingly, MS analyses have revealed the presence of ether lipids in exosomes (Tables 1, 2 ). Ether lipids are mainly found as PC and PE, although these lipids can be long to several phospholipid classes. Alkenyl ethers (vinyl ethers) are often called plasmalogens, and PE plasmalogens can constitute up to 50% of the PE lipids in organs such as brain, kidney, and heart (71). Rather larger amounts of ether lipids have been reported in exosomes released from PC3 cells (36, 38) , mast cells (41), and platelets (45); and surprisingly, all PE species detected in exosomes from hu man urine were identified as PE ethers (63) . Interestingly, it has been shown that the amount of ether lipids in exo somes can be regulated, as shown in a study where an ether lipid precursor was added to PC3 cells (38) .
The lipid composition of exosomes secreted from a nematode parasite has also been analyzed (Table 2 ) (74). The exosomes released from this parasite showed a re markable lipid composition with a very high content of PE plasmalogens (47 mol%) and very small amounts of CHOL (7 mol%) and SM (3 mol%) (74) . Furthermore, a PE ether with 36 carbon atoms and two double bonds in the hydro phobic chains made up approximately 25% of the total lipids, and these exosomes also contained a remarkably high content of phospholipids with a total of two double bonds in the two fatty acyl chains. The authors speculated that the high plasmalogen content was necessary for the stability of these vesicles and compensated for the low levels of CHOL and SM. The metabolic pathways, including sphingolipid synthesis, are not very well described in nematodes, and it is believed that all sterols are obtained through the diet (74) . Interestingly, it has been shown that HIV particles also have a high content of PE ethers (75) .
Ether phospholipids have been reported to be involved in membrane trafficking and cell signaling and differenti ation, and to possibly function as cellular antioxidants (68, 72) . These lipids have also been reported to facilitate membrane fusion (76) and to behave differently from their corresponding fatty acyl analogs. The etherlinked alkyl/ alkenyl group probably enters perpendicularly into the membrane; whereas in phospholipids, the two first carbon atoms of the sn-1 acyl groups are almost parallel to the plasma membrane, while the rest of the acyl chain bends and enters the bilayer. This was first shown for PC alkenyl ethers by magnetic resonance spectroscopy (77) (78) . The pres ence of ether lipids in exosomes may therefore have im portant implications both for their fusion with other membranes and for their stability in the extracellular space. Interestingly, it has been shown that ether glycero phospholipids provided rigidity to the membranes of nematode exosomes, but did not affect their fusion effi ciency (74) . Concerning the study of ether lipids in PC3 cells, the cells treated with the ether lipid precursor con tained fewer MVBs and fewer ILVs per MVB. It was specu lated that this was caused by less mature MVBs, with fewer ILVs, due to an increased fusion of mature MVBs with the plasma membrane (38) .
Ether lipids have a unique metabolism; for example, there is an ether phospholipidspecific phospholipase A2 that cleaves off fatty acyl groups from the sn-2 position (79). This is very relevant for the release of arachidonic acid (C20:4), often present in this position, which is known to be important both in cellular signaling and as a precursor for the synthesis of eicosanoids (80) . The level of ether phospholipids has also been shown to be important for the cellular level of CHOL, as it is important for the stability of squalene monooxygenase, a key enzyme in the CHOL syn thesis pathway. Surprisingly, it has been shown that both elevated and low amounts of PE plasmalogens lower the levels of CHOL (71).
COMPOSITION OF LIPID SPECIES IN EXOSOMES
So far, only a few lipidomic studies of exosomes contain quantitative data for large numbers of lipid species, but re cent advancements in MSbased lipidomics are expected to facilitate these studies in the future. It has often been re ported that the saturation level of the fatty acyl groups in phospholipids is higher in exosomes than in the parent cells. For PC, this is mainly due to an increase in PC 14:0/16:0 and PC 16:0/16:0 (30, 36) . In our opinion, it may be even more important to stress the high percentage of phospholipids in exosomes that contain one unsatu rated fatty acyl group, e.g., PC 16:0/18:1 and PC 16:0/16:1 are the most abundant PC species in PC3 cells (36) and Olineu cells (30) . Moreover, PC 34:1 constituted approxi mately 60% of the PC species in the two preparations of prostasomes listed in Table 2 (62) . In addition, exosomes secreted from PC3 cells are also enriched in other phos pholipids having C18:1 in the sn-2 position, as shown by the remarkably high content and enrichment of PS 18:0/18:1 (36), for example. This PS species was also the second most abundant species in exosomes isolated from human urine, where CHOL is the most abundant lipid (63) . The similar enrichment of CHOL, PS 18:0/18:1, and the verylong chain sphingolipids in exosomes secreted from PC3 cells made us hypothesize that there is a handshaking (trans membrane coupling between fatty acyl chains present in dif ferent membrane leaflets) between these sphingolipids in the outer leaflet and PS 18:0/18:1 in the inner leaflet of the exosomal membranes (36) . Further evidence for such a handshaking between the two leaflets was obtained by molecular dynamic simulation studies of the interdigita tion between these lipids in the presence of CHOL (81) . This led us to propose a model for the interaction between these two leaflets that is discussed in detail in a recent review (18) .
It should be mentioned that this model assumes that the outer and the inner lipid layers of the exosomal mem branes have the same orientation as in the plasma mem brane, as can be expected from the mechanism of exosome formation. Therefore, PS, or at least most of it, is assumed to be located in the inner leaflet of exosomes. Several stud ies have concluded that PS is present in the outer leaflet of exosomes, as it can be detected by using PSbinding pro teins, such as annexin 5 and TIM4 (82, 83) . PS is, in fact, known to be located in the outer leaflet of activated blood cells, apoptotic bodies, and microparticles or microvesicles released from the plasma membrane, where it acts as an "eat me" signal for macrophages (84) . There is increasing evidence that exosomes can transfer signals to other cells and organs, and the presence of PS on the exosome sur face is not in agreement with this role, as exosomes would be rapidly removed from circulation. Different isolation protocols may lead to preparations containing different types of EVs, and it should be checked to determine whether the population of EVs showing surface exposure of PS are indeed exosomes. Two recent studies of EVs se creted from human bone marrow mesenchymal stem cells are very interesting regarding this discussion. In one of them, the release of EVs from hypoxic and nonhypoxic cells was investigated. Interestingly, only the vesicles (ex pected to be a mixture of exosomes and microvesicles) re leased from hypoxic cells were reported to expose PS on their surface (85) . In the other study, three different types of EVs (size diameter of 50-100 nm) were analyzed, and the only vesicle population shown to bind annexin 5 car ried low or undetectable levels of exosomal markers, such as CD9, CD81, ALIX, and TSG101 (86) . Based on this dis cussion, we conclude that more studies are needed to es tablish whether PS is present in the outer leaflet of exosomes when they are secreted, or whether PS translo cates during storage.
PIPs AND EXOSOMES
As mentioned earlier, PIPs are phosphorylated derivates of the membrane phospholipid, PI. Seven PIPs have been identified, and they can be converted into each other by phosphorylation or dephosphorylation of the 3, 4, and 5hydroxyl groups of the inositol head group by phos phoinositide kinases (PIKs) and phosphatases, respectively [for excellent reviews on PIPs, see (55, 56) ]. PIPs serve as precursors for specific second messengers involved in signal transduction and, importantly, help to specify organelle identity and regulate membrane dynamics and vesicular transport by recruiting cytosolic proteins containing specific recognition domains to membranes (56, 87) . PI(3,5)P 2 , a PIP produced from PI(3)P by the action of the PIP kinase, PIKfyve, is known to be associated with MVBs (88, 89) . Due to the role of PIPs in membrane dynamics and vesicular transport, it is not surprising that this lipid may affect exosome secretion. In fact, we have recently shown that inhibition of the formation of PI(3,5)P 2 by knockdown of PIKfyve with siRNA or by addition of a PIK fyve inhibitor increases exosome secretion in PC3 cells (26) . In addition, this treatment also induced secretory au tophagy (26) . Autophagy is a degradative pathway that sup plies nutrients during starvation and eliminates damaged organelles, aggregated proteins, and invading pathogens (90) . This pathway can be induced by various stimuli to maintain cellular homeostasis. Upon induction of autoph agy, cytoplasmic cargo is trapped within doublemembrane vesicles termed autophagosomes, which then fuse with MVBs to form amphisomes or directly with lysosomes (90) for cargo degradation (Fig. 1) . In addition, the autophagic machinery is used to secrete numerous cytoplasmic sub strates by a process called secretory autophagy (13, 14) . Be cause the content released by amphisomes might be coisolated with exosomes during the exosome isolation process, it may be difficult to distinguish exosome secre tion from secretory autophagy (26) . After PIKfyve inhibi tion, more MVBs with an increased number of ILVs as well as reduced autophagic degradation were observed in PC3 cells (26) . A possible explanation for this effect could be that the fusion of lysosomes with both MVBs and autopha gosomes was impaired under these conditions (Fig. 1) . The reported ability of PI(3,5)P 2 to act as an agonist for the lysosomal Ca 2+ channel TRPML1 may be related to the impaired fusion of MVBs with lysosomes observed after reduction of the PI(3,5)P 2 levels (91). In agreement with the role of PIPs in exosome release, it has also been shown that inhibition of the class I PI(3)P kinase or Akt, a downstream component in PI3K signaling, increased the exosomal re lease of angiopoietin2 from lung endothelial cells (92) .
In addition to the above mentioned results of PIKfyve inhibition, there are other studies that support the exis tence of a link between autophagy and exosome biogenesis and release (93) . Fader et al. (94) showed that induction of autophagy by starvation reduced exosome release. The au thors proposed that this was due to an increased fusion of MVBs with autophagosomes, thereby directing MVBs to the degradative pathway. Furthermore, it has recently been reported that depletion of PI(3)P, the major PIP control ling autophagy (55) , by inhibition of Vps34 (a class III PI3K), inhibits autophagy initiation, impairs lysosomal deg radation, and promotes secretion of exosomes enriched in undigested lysosomal products (54) . However, it is not clear whether the undigested lysosomal products were actually inside the exosomes or whether the observed atypical exosome pellet also contained products from secretory au tophagy. Moreover, several reports have shown a role for autophagyrelated genes (Atgs) in exosome formation and release (95) (96) (97) . However, the role of some of the investi gated Atgs seems to be independent of their function in canonical autophagy. For example, Guo et al. (95) have recently reported that Atg5 depletion reduces exosome release by impairing the disassociation of the V 1 V 0 ATPase, a proton pump that mediates the acidification of endo somes and lysosomes. Finally, in addition to autophagy studies, there are other reports showing that cellular homeostasis seems to affect the machinery utilized for exosome biogenesis and/or release (98) (99) (100) (101) (102) .
CONCLUSIONS
Lipids are important components of exosomes, and several studies demonstrate that they play an important role in the biology of these vesicles. Exosomes are enriched in sphingolipids, CHOL, and PS compared with the donor cells. Interestingly, the lipid composition of exosomes shows similarities with lipid rafts, and exosomes have a higher lipid order and a higher stability against detergents than other EVs. Some exosome preparations have a high content of PE ethers, and more studies are required to in vestigate the function of these lipids. We also need more quantitative lipidomic studies of exosomes and informa tion about their lipid species. Increasing our knowledge on lipids will help to better understand the biology of exo somes and to facilitate the future exploitation of exosomes in the clinic.
